Results 41 to 50 of about 2,502 (176)

Surface Active Agents: Chemical Types and Applications [PDF]

, 1945
Newsletter providing "a lighter, human interest side of the news" from the Boston University Medical ...
Boston University Medical Center, Brayton, Josephine, Dolan, Barbara   +2 more
core   +1 more source

Northwest Iranian dermatophyte isolates: anthropophilic and geophilic [PDF]

Current Medical Mycology
Background and Purposes: The fungi known as dermatophytes are a group of keratinophilic agents responsible for superficial infections in humans and animals. Recognition of the species distribution and epidemiology of dermatophytosis may be helpful in the
Kambiz Diba, Kosar Jafari, Kasra Alizadeh, Narges Aslani   +3 more
doaj   +1 more source

Post endodontic Aspergillosis in an immunocompetent individual [PDF]

, 2015
Non-invasive aspergillosis in immunocompetent individuals subsequent to post endodontic treatment can involve the maxillary antrum. An early and accurate diagnosis will aid in prompt and effective treatment. A 35 year old female patient reported with a
Gupta, Shalini, Mohanty, Sujata, Nunia, Kalpana, Singh, Hanspal, Urs, Aadithya-Basavaraj   +4 more
core   +2 more sources

A review of cutaneous toxicities from targeted therapies in the treatment of colorectal cancers [PDF]

, 2013
Currently there are three targeted therapies approved for the treatment of colorectal cancers. These include the epidermal growth factor receptor (EGFR) inhibitors, cetuximab and panitumumab, and the multikinase inhibitor regorafenib.
Anadkat, Milan J, Urban, Christopher
core   +2 more sources

Topical diclofenac: Clinical effectiveness and current uses in osteoarthritis of the knee and soft tissue injuries [PDF]

, 2008
Background: Diclofenac is a commonly used non-steroidal anti-inflammatory drug (NSAID) for symptom control in osteoarthritis (OA) of the knee and soft tissue injuries.
Banning, M
core   +1 more source

Successful Treatment of an Adult with Atopic Dermatitis and Lamellar Ichthyosis Using Dupilumab

Biologics: Targets & Therapy, 2022
Faisal K Binkhonain, Sara Aldokhayel, Hessah BinJadeed, Abdulaziz Madani Dermatology Department, College of Medicine, King Saud University, Riyadh, Saudi ArabiaCorrespondence: Abdulaziz Madani, Dermatology Department, King Saud University, Riyadh, 7805 ...
Binkhonain FK, Aldokhayel S, BinJadeed H, Madani A   +3 more
doaj  

KOH 5% solution versus diclofenac 3% for the treatment of actinic keratosis – Results from a three‐armed RCT

Journal of the European Academy of Dermatology and Venereology, EarlyView.
In this RCT, KOH 5% demonstrated superior clinical success to diclofenac 3% and placebo at the end of treatment in patients with mild‐to‐moderate actinic keratosis and comparable long‐term efficacy to diclofenac. Its fast onset of efficacy and favourable tolerability make KOH a valuable treatment option in early‐stage actinic keratosis treatment ...
U. Reinhold, N. Leitz, R. Dominicus, E. L. Szabó, T. Dirschka, G. Popp, T. C. Fischer, N. Adamini, R. Ostendorf, M. Asefi, H. Durani, T. Hölting, U. Amann, F. Kreuziger, T. Assmann, H. Brüning, L. Freitag, K. Hoffmann, R. Gedschold   +18 more
wiley   +1 more source

Evaluation of the effectiveness of Eladi Keram for the treatment of acne vulgaris: a randomised controlled pilot study [PDF]

, 2017
Introduction: Acne is a multifactorial and common skin disease which can significantly affect the quality of life of sufferers. In this study, a topical herbal preparation traditionally used in Ayurvedic medicine was evaluated as a treatment for ...
Abdel Hay, Agnihotri, Ammon, Aruldass, Bae, Benjamin Lawley, Bhambri, Burke, Celia Bell, Chaitanya, Chaurasia, Chen, Cross, Cunha, Das, Dash, Dawson, Dessinioti, Dieu Thuan, Dumont-Wallon, Dutta, Francis, Ghosh, Gokhale, Gopalakrishnan, Hasson, Hassoun, Hong, Huw Jones, Karthy, Kaur, Kaushik, Kaushik, Khorasani, Khuda, Kimmatkar, Kubo, Kumar, Kurokawa, Leyden, Majdalawieh, McCarty, Milan Vu, Mukherjee, Nasri, Nishteswar, Oikawa, Parveen, Poma, Raja, Ramesh, Richter, Said, Sandhya, Sandra Appiah, Satyal, Saurat, Schofield, Shafiei, Shah, Sharma, Shinde, Soni, Su, Tara Shanbhag, Tewtrakul, Thiboutot, Tsai, Wani, Wanner, Watson, Wolf, Yadav, Zeng, Zu   +74 more
core   +1 more source

Practical recommendations for seborrheic dermatitis management: An expert consensus

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This modified Delphi study established expert consensus on Seborrheic Dermatitis management. Key findings prioritize combined topical antifungal and anti‐inflammatory therapy for both acute flares and long‐term maintenance. The consensus also provides a clear framework for escalating to systemic treatment in extensive or refractory cases.
L. Naldi, A. Kyrgidis, G. S. Tiplica, M. A. de Rie, D. Tatsis, P. Gisondi, D. Ioannides, O. Chosidow, M. Deleuran, the Delphi SD study experts   +9 more
wiley   +1 more source

Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68‐week randomized Phase 3 trial

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 887-899, May 2026.
This open‐label study is a continuation of the 16‐week double‐blind, Phase 3 trial assessing the efficacy and safety of brodalumab 210 mg subcutaneously, till a 68‐week extension period. Continued improvement was seen in the PPPASI 50/75/90 responses, PPPSI scores, PGA 0/1 responses and DLQI. Abstract Background The efficacy and safety of brodalumab in
Masamoto Murakami, Yukari Okubo, Satomi Kobayashi, Natsuko Kikuta, Yoshiumi Ouchi, Kenta Shishido, Tadashi Terui   +6 more
wiley   +1 more source